Spomenka K. P.
- Country
- Croatia
- Department
- Department of Neurology
Research Overview
Data & Insights
Has run more than one trial at 7 of 39 partner sites.
Specializations
Multiple Sclerosis and Demyelinating Disease
The investigator is engaged in clinical research across the spectrum of multiple sclerosis, with a strong focus on relapsing and progressive disease forms, including relapsing-remitting multiple sclerosis, primary progressive multiple sclerosis, and secondary progressive multiple sclerosis. This work also extends to treatment evaluation in patients with active inflammatory disease and disability progression.
- Relapsing forms of multiple sclerosis
- Primary progressive multiple sclerosis
- Secondary progressive multiple sclerosis
- Ocrelizumab
- Ublituximab
- Remibrutinib
Her neurology portfolio includes interest in anti-CD20 therapies, B-cell depletion, and agents targeting relapse reduction and MRI-defined disease activity.
Cardiovascular Disease and Thromboembolic Prevention
Her research activity includes cardiovascular risk reduction and prevention of thromboembolic complications in patients with atrial fibrillation, chronic heart failure, and high-risk vascular disease. The therapeutic scope also includes strategies aimed at reducing major cardiovascular events and stroke-related outcomes.
- Atrial fibrillation
- Chronic heart failure
- Acute ischemic stroke
- Transient ischemic attack
- Atherosclerotic cardiovascular disease
- Inclisiran
- Milvexian
- Finerenone
Her clinical interest also covers heart failure with preserved or reduced ejection fraction and therapies addressing both vascular protection and event prevention.
Metabolic Disease and Weight Management
The investigator is involved in studies of type 2 diabetes, overweight, and obesity, with attention to glycaemic control and body-weight reduction. This area includes evaluation of therapies designed for patients with inadequate metabolic control despite standard treatment.
- Type 2 diabetes
- Overweight
- Obesity
- CagriSema
- NNC0487-0111
- NNC0662-0419
Her therapeutic focus includes glucose-lowering treatment and interventions that combine metabolic control with weight management.
Neuropsychiatric and Respiratory Conditions
Her clinical trial involvement also spans agitation associated with Alzheimer’s disease and moderate-to-severe uncontrolled asthma, reflecting interest in symptom-directed treatment across neurologic and respiratory disorders. These studies address challenging clinical manifestations that affect daily function and disease burden.
- Agitation associated with Alzheimer’s disease
- Alzheimer’s disease
- Moderate-to-severe uncontrolled asthma
- KarXT
- Atuliflapon
Her work in this domain includes attention to behavioral symptoms in dementia and treatment options for persistent airway inflammation.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.